Prof Susan Connor

Professor Susan Connor

Gastroenterologist and Hepatologist

BMedSci UNSW, MBBS (Hons 1) UNSW, FRACP, PhD UNSW
Head of IBD service at Liverpool Hospital
Senior Staff Specialist at Department of Gastroenterology and Liver

  Research interests:
Biologic level testing, patient centred tools for IBD, quality improvement in colonoscopy and tools to facilitate IBD care for gastroenterologists

  Clinical Expertise:
Inflammatory Bowel Disease, Bowel Cancer Screening

Profile

Professor Susan Connor is Head of the Inflammation Bowel Disease (IBD) service at the Liverpool Hospital in Sydney where she also serves as a Senior Staff Specialist and a Conjoint Associate Professor with the University of New South Wales (UNSW). Prof Connor obtained her Bachelor of Medicine and Bachelor of Surgery from the University of New South Wales in 1991, graduating with first class honours. She undertook residency at Prince of Wales/Prince Henry Hospitals before continuing her training as a Physician in Gastroenterology at Concord Hospital. Following this Prof Connor obtained her Fellowship at the Royal Australian College of Physicians in 1998. In 2005, she completed her PhD on mucosal immunology in IBD at UNSW and received a postgraduate NHMRC fellowship.

Prof Connor is on the management committee for the Australian and New Zealand IBD Consortium, Chair for the Australian IBD Association and one of two Australian faculties for Cornerstones Health. Her clinical interests encompass IBD, advocating the improvement of patient care for bowel disease and promoting models for chronic disease management. As well as this her passion is in developing better training environments for medical doctors and improving research within the South Western Sydney Local Health District (SWSLHD), expanding throughout Australia and New Zealand. In 2015, Prof Connor was awarded a SWSLHD Mid-Career Researcher Award, which included a three year research grant.

Education

B Med Sci (Distinction)
University of New South Wales 1989

MBBS (Hons class 1)
University of New South Wales 1991

FRACP
Royal Australian College of Physicians 1998

Ph.D. in Medicine Dissertation
“The role of chemokine receptors in Inflammatory Bowel Disease” University of New South Wales

Positions

Staff Specialist, Gastroenterologist and Hepatologist (2004 – present)
Department of Gastroenterology and Liver, Liverpool Hospital

Conjoint Associate Professor (2015 - 2022)
University of New South Wales

Conjoint Professor (2022 - present)
University of New South Wales

Chairperson General Clinical Training Committee (2016 - present)
Liverpool Hospital

Member Biosimilar Awareness Initiative Reference Group (2016 – present)
Department of Health, ACT

Member National Examining Panel (2016 - present)
Royal Australasian College of Physicians

Academic Physician Member on South Western Sydney LHD (2015 - present)
South Western Sydney Local Health District

Member of Executive of AIBDA Chair Elect Aug 2017-2019
Australian Inflammatory Bowel Disease Association (AIBDA) within GESA

Australian Faculty for Cornerstones Health (2013 - present)
Cornerstones Health: Cornerstonehealth.org

Advisory Board Member (2012 - present)
Janssen Cilag Australia, Abbvie Australia, Takeda Australia, Pfizer Australasia, Ferring Pharmaceuticals Australasia, Vifor Global, MSD Australia, Celgen Australia

Member Management Committee of ANZIBDC (2012 - present)
Australian and New Zealand Inflammatory Bowel Disease Consortium (ANZIBDC)

Select Publications

  1. Gu B, De Gregorio M, Pipicella JL, Vande Casteele N, Andrews JM, Begun J, Connell W, D'Souza B, Gholamrezaei A, Hart A, Liew D, Radford-Smith G, Rimola J, Sutherland T, Toong C, Woods R, Wu Y, Xuan W, Williams AJ, Ng W, Ding NS, Connor S. Prospective randomised controlled trial of adults with perianal fistulising Crohn's disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol. BMJ Open. 2021;11(7):e043921. DOI: 10.1136/bmjopen-2020-043921

  2. Kim AH, Girgis A, De Cruz P, Siegel CA, Karimi N, Ruban SO, Sechi AJ, Ng WSW, Andrews JM, Connor SJ. Development and Feasibility of a Web-Based Decision Aid for Patients With Ulcerative Colitis: Qualitative Pilot Study. J Med Internet Res. 2021; 23(2):e15946. DOI: 10.2196/15946

  3. Krishnaprasad K, Walsh A, Begun J, Bell S, Carter D, Grafton R, Sechi A, Sewell K, McMahon A, Connor S, Radford-Smith G, Andrews JM. Australia and New Zealand Inflammatory Bowel Disease Consortium and Crohn's Colitis Cure. Crohn's Colitis Care (CCCare): bespoke cloud-based clinical management software for inflammatory bowel disease. Scand J Gastroenterol. 2020;55(12):1419-1426. DOI: 10.1080/00365521.2020.1839960

  4. An YK, Prince D, Gardiner F, Neeman T, Linedale EC, Andrews JM, Connor S, Begun J. Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta-analysis. Med J Aust. 2019;211(10):461-467. DOI: 10.5694/mja2.50384

  5. Paramsothy S, Kamm MA, Kaakoush NO, Walsh AJ, van den Bogaerde J, Samuel D, Leong RWL, Connor S, Ng W, Paramsothy R, Xuan W, Lin E, Mitchell HM, Borody TJ. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet. 2017;389(10075):1218-1228. DOI: 10.1016/S0140-6736(17)30182-4

If you have any enquiries or would like to make an appointment, please email:

Gastroenterology and Liver
Clinic E (123), Level 1
Liverpool Hospital
Corner of Elizabeth and Goulburn Streets
LIVERPOOL NSW 2170

  02 8738 4085
  FAX: 02 8738 3094
Due to COVID-19 changes, our phones cannot always be answered, so the best way to contact us is via email or fax

8.30am - 4.00pm
Monday to Friday

© 2014-2022 Department of Gastroenterology & Liver, Liverpool Hospital | Privacy Policy | Disclaimer | Website design: WebInjection